Kentaro Hanada

Dr. Kentaro Hanada

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2003 in Nature
Verified
Journal Article
Closed access
PDF file
KHKentaro Hanada
Kentaro Hanada
KKKeigo Kumagai
Keigo Kumagai
SYSatoshi Yasuda
Satoshi Yasuda
YMYukiko Miura
Yukiko Miura
MKMiyuki Kawano
Miyuki Kawano
MNMasahiro Nishijima
Masahiro Nishijima

1 June 2003 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
KHKentaro Hanada
Kentaro Hanada

28 September 2014 in DNA Research
Verified
Journal Article
Open access
PDF file
NONaoki Osada
Naoki Osada
AKArihiro Kohara
Arihiro Kohara
TYToshiyuki Yamaji
Toshiyuki Yamaji
NHNoriko Hirayama
Noriko Hirayama
FKFumio Kasai
Fumio Kasai
KHKentaro Hanada
Kentaro Hanada
Continuous cell lines that originate from mammalian tissues serve as not only invaluable tools for life sciences, but also important animal cell substrates for the production of various types of biological pharmaceuticals. Vero cells are susceptible to various types of microbes and toxins and have widely contributed to not only microbiology, but also the production of vaccines for human use. We here showed the genome landscape of a Vero cell line, in which 25,877 putative protein-coding genes were identified in the 2.97-Gb genome sequence. A homozygous ∼9-Mb deletion on chromosome 12 caused the loss of the type I interferon gene cluster and cyclin-dependent kinase inhibitor genes in Vero cells. In addition, an ∼59-Mb loss of heterozygosity around this deleted region suggested that the homozygosity of the deletion was established by a large-scale conversion. Moreover, a genomic analysis of Vero cells revealed a female Chlorocebus sabaeus origin and proviral variations of the endogenous simian type D retrovirus. These results revealed the genomic basis for the non-tumourigenic permanent Vero cell lineage susceptible to various pathogens and will be useful for generating new sub-lines and developing new tools in the quality control of Vero cells.

15 January 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NKNorio Kudo
Norio Kudo
KKKeigo Kumagai
Keigo Kumagai
NTNario Tomishige
Nario Tomishige
TYToshiyuki Yamaji
Toshiyuki Yamaji
SWSoichi Wakatsuki
Soichi Wakatsuki
RKRyuichi Kato
Ryuichi Kato
In mammalian cells, ceramide is synthesized in the endoplasmic reticulum and transferred to the Golgi apparatus for conversion to sphingomyelin. Ceramide transport occurs in a nonvesicular manner and is mediated by CERT, a cytosolic 68-kDa protein with a C-terminal steroidogenic acute regulatory protein-related lipid transfer (START) domain. The CERT START domain efficiently transfers natural d -erythro-C 16 -ceramide, but not lipids with longer (C 20 ) amide-acyl chains. The molecular mechanisms of ceramide specificity, both stereo-specific recognition and length limit, are not well understood. Here we report the crystal structures of the CERT START domain in its apo-form and in complex with ceramides having different acyl chain lengths. In these complex structures, one ceramide molecule is buried in a long amphiphilic cavity. At the far end of the cavity, the amide and hydroxyl groups of ceramide form a hydrogen bond network with specific amino acid residues that play key roles in stereo-specific ceramide recognition. At the head of the ceramide molecule, there is no extra space to accommodate additional bulky groups. The two aliphatic chains of ceramide are surrounded by the hydrophobic wall of the cavity, whose size and shape dictate the length limit for cognate ceramides. Furthermore, local high-crystallographic B -factors suggest that the α-3 and the Ω1 loop might work as a gate to incorporate the ceramide into the cavity. Thus, the structures demonstrate the structural basis for the mechanism by which CERT can distinguish ceramide from other lipid types yet still recognize multiple species of ceramides.

1 July 2009 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
KHKentaro Hanada
Kentaro Hanada
KKKeigo Kumagai
Keigo Kumagai
NTNario Tomishige
Nario Tomishige
TYToshiyuki Yamaji
Toshiyuki Yamaji

1 December 1998 in Journal of Biological Chemistry
Verified
Journal Article
Open access
KHKentaro Hanada
Kentaro Hanada
THTomoko Hara
Tomoko Hara
MFMasayoshi Fukasawa
Masayoshi Fukasawa
AYAkiko Yamaji
Akiko Yamaji
MUMasato Umeda
Masato Umeda
MNMasahiro Nishijima
Masahiro Nishijima
Lysenin, a hemolytic protein derived from the earthworm Eisenia foetida, has a high affinity for sphingomyelin. Chinese hamster ovary (CHO) cells exhibited a high cytolytic sensitivity to lysenin, but treatment with sphingomyelinase rendered the cells resistant to lysenin. Temperature-sensitive CHO mutant cells defective in sphingolipid synthesis were resistant to lysenin, and this lysenin resistance was suppressed by metabolic complementation of sphingolipids. Selection of lysenin-resistant variants from mutagenized CHO cells yielded two types of sphingomyelin-deficient mutants, both of which showed less lysenin binding capability than wild-type cells. One mutant strain was severely defective in sphingomyelin synthesis but not glycosphingolipid synthesis, and another strain (designated LY-B) was incapable of de novo synthesis of any sphingolipid species and had no activity of serine palmitoyltransferase (SPT; EC 2.3.1.50) catalyzing the first step of sphingolipid biosynthesis. LY-B cells lacked the LCB1 protein, a component of SPT, and transfection of LY-B cells with the hamster LCB1 cDNA restored both SPT activity and sphingolipid synthesis to the cells. Expression of an affinity peptide-tagged LCB1 protein in LY-B cells caused the endogenous LCB2 protein to adsorb to a tag affinity matrix. In addition, an anti-hamster LCB2 protein antibody co-immunoprecipitated both SPT activity and the wild-type LCB1 protein with the LCB2 protein. Thus, cell surface sphingomyelin is essential for lysenin-induced cytolysis, and lysenin is a useful tool for isolation of sphingomyelin-deficient mutants. Moreover, these results demonstrate that the SPT enzyme comprises both the LCB1 and LCB2 proteins.